Tilman Brummer
Impact in
- Oncology top 2%
- Cancer Cells and Metastasis
- Immunology top 5%
- Immune Cell Function and Interaction
Papers in
-
- Melanoma and MAPK Pathways 25
- Protein Tyrosine Phosphatases 14
- Ubiquitin and proteasome pathways 12
- Protein Kinase Regulation and GTPase Signaling 11
- 14-3-3 protein interactions 7
- Signaling Pathways in Disease 7
- PI3K/AKT/mTOR signaling in cancer 7
- Oncology 28
- Co-authors
- Roger J. Daly (14 shared papers)Philippa M. O’Brien (2 shared papers)Kate Patterson (3 shared papers)Michael Reth (7 shared papers)Robert Zeiser (14 shared papers)Ricarda Herr (12 shared papers)Olaf Groß (1 shared paper)Shaima’a Hamarsheh (2 shared papers)
- Journals
- Oncogene (8 papers)Cell Communication and Signaling (8 papers)Oncotarget (5 papers)The EMBO Journal (5 papers)Nature Communications (4 papers)
- Partner nations
- GermanyAustraliaUnited States
In The Last Decade
Tilman Brummer
95 papers receiving 4.4k citations
Tilman Brummer's Hit Papers
Peers
Comparison fields: 5 of 114
- Oncology 1.1k
- Immunology 857
- Molecular Biology 2.8k
- Cancer Research 504
- Cell Biology 461
Countries citing papers authored by Tilman Brummer
This map shows the geographic impact of Tilman Brummer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilman Brummer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilman Brummer more than expected).
Fields of papers citing papers by Tilman Brummer
This network shows the impact of papers produced by Tilman Brummer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilman Brummer. The network helps show where Tilman Brummer may publish in the future.
Co-authors
The 25 scholars most cited alongside Tilman Brummer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dual-specificity phosphatases: critical regulators with diverse cellular targets Hit paper breakdown → | 2009 | 603 |
| 2 | 2020 | 250 | |
| 3 | 2016 | 246 | |
| 4 | 2006 | 224 | |
| 5 | 2004 | 169 | |
| 6 | 2002 | 157 | |
| 7 | 2011 | 156 | |
| 8 | 2015 | 148 | |
| 9 | 2009 | 137 | |
| 10 | 2012 | 106 | |
| 11 | 2005 | 102 | |
| 12 | 2003 | 93 | |
| 13 | Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinoma Hit paper breakdown → | 2022 | 91 |
| 14 | 2017 | 88 | |
| 15 | 2004 | 75 | |
| 16 | 2010 | 70 | |
| 17 | 2016 | 67 | |
| 18 | 2002 | 66 | |
| 19 | 2013 | 56 | |
| 20 | 2006 | 55 |
About Tilman Brummer
Tilman Brummer is a scholar working on Molecular Biology, Oncology, Immunology, Pathology and Forensic Medicine and Genetics, having authored 99 papers that have together received 4.5k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (25 papers), Protein Tyrosine Phosphatases (14 papers), Ubiquitin and proteasome pathways (12 papers), Protein Kinase Regulation and GTPase Signaling (11 papers), Cancer Mechanisms and Therapy (9 papers), 14-3-3 protein interactions (7 papers), Signaling Pathways in Disease (7 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). The work is most often cited by research in Oncology (1.1k citations), Immunology (857 citations), Molecular Biology (2.8k citations), Cancer Research (504 citations) and Cell Biology (461 citations). Tilman Brummer has collaborated with scholars based in Germany, Australia and United States. Frequent co-authors include Roger J. Daly, Philippa M. O’Brien, Kate Patterson, Michael Reth, Robert Zeiser, Ricarda Herr, Olaf Groß, Shaima’a Hamarsheh, Michael Röring and Hassan Jumaa. Their work appears in journals such as Oncogene, Cell Communication and Signaling, Oncotarget, The EMBO Journal and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.